Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

China Developers to Build $1.5 Billion Life Science Park in South San Francisco

publication date: Aug 18, 2016
A China real estate developer and several China investment funds will spend $1.5 billion to develop a major biopharma site in South San Francisco, a project that will focus on fostering China-US cooperation in life sciences. The Oyster Point site was acquired by Greenland Holdings, a state-backed developer, plus Agile Group, Ping An Trust and Poly Sino Capital. When fully developed, the site could support over 2.2 million feet of office space, which is expected to be devoted entirely to life science companies. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital